(Approval lapsed) Sertraline 100mg film-coated tablets (Ranbaxy UK)
Section 19A approved medicine
(Approval lapsed) Sertraline 100mg film-coated tablets (Ranbaxy UK)
Section 19A approval holder
Barwon Pharma Pty Ltd ABN 93 169 715 066
Phone
0427 902 599
Approved until
Status
Expired
Medicines in short supply/unavailable
APO-SERTRALINE sertraline (as hydrochloride) 100mg tablet blister pack - ARTG 213180
ELEVA 100 sertraline (as hydrochloride) 100 mg tablet blister pack - ARTG 95583
SERTRALINE SANDOZ sertraline 100mg (as hydrochloride) film coated tablet blister pack - ARTG 98698
SERTRA 100 sertraline (as hydrochloride) 100 mg tablet blister pack - ARTG 213181
SETRONA sertraline (as hydrochloride) 100 mg tablet blister pack - ARTG 116636
ZOLOFT sertraline (as hydrochloride) 100 mg tablet blister pack - ARTG 321602
SERTRALINE GENERICHEALTH sertraline 100mg (as hydrochloride) tablet blister pack - ARTG 124856
ELEVA 100 sertraline (as hydrochloride) 100 mg tablet blister pack - ARTG 95583
SERTRALINE SANDOZ sertraline 100mg (as hydrochloride) film coated tablet blister pack - ARTG 98698
SERTRA 100 sertraline (as hydrochloride) 100 mg tablet blister pack - ARTG 213181
SETRONA sertraline (as hydrochloride) 100 mg tablet blister pack - ARTG 116636
ZOLOFT sertraline (as hydrochloride) 100 mg tablet blister pack - ARTG 321602
SERTRALINE GENERICHEALTH sertraline 100mg (as hydrochloride) tablet blister pack - ARTG 124856
Indication(s)
Indicated for the treatment of children (aged 6 years of age and older) and adolescents with obsessive compulsive disorder (OCD).
Indicated in adults for the treatment of:
- Major depression
- Obsessive compulsive disorder (OCD)
- Panic disorder
- Social phobia (social anxiety disorder) and the prevention of its relapse
- Pre-menstrual dysphoric disorder (PMDD) as defined by DSM-IV criteria
Images
